Publicaciones

  1. Wu L. The Omnipresence of Vascular Endothelial Growth Factor in Retinal Diseases. Taiwan J Ophthalmol 2019;9:213-215.
  2. Wu L, Acon D, Wu A, Wu M. Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm? Taiwan J Ophthalmol 2019;9:216-223
  3. Flikier S, Wu A, Wu L. Revisiting Pars Plana Vitrectomy in the Primary Treatment of Diabetic Macular Edema in the Era of Pharmacological Treatment. Taiwan J Ophthalmol 2019;9:224-232.
  4. Chawan-Saad J, Wu M, Wu A, Wu L. Corticosteroids for Diabetic Macular Edema. Taiwan J Ophthalmol 2019;9:233-242
  5. Sahoo NK, Govindhari V, Bedi R, Goud A, Singh R, Wu L, Chhablani J. Subretinal Hyperreflective Material in Central Serous Chorioretinopathy. Indian J Ophthalmol 2020;68:126-129
  6. Viquez MV, Wu L. Sensitivity and Specificity of the Red Reflex in Costa Rican Newborns. Arch Soc Esp Oftalmol 2019 Dec 8. pii: S0365-6691(19)30307-7. doi: 10.1016/j.oftal.2019.10.007. [Epub ahead of print]
  7. Conti FF, Alezzandrini A, Rasendran C, Nakhwa C, Neves D, Queiroga FS, Chhablani J, Rocha J, Martins RP, Romero J, Wu L, Han M, Gurjar RK, Haq S, Lee S, Natarajan S, Ansari WH, Yoon YH, Singh RP; Global Diabetic Macular Edema Study Group. An International Comparison of Baseline Characteristics of Patients Undergoing Initiation of Anti-VEGF Therapy for DME. Ophthalmic Surg Lasers Imaging Retina. 2019 Nov 1;50(11):e300-e310. doi: 10.3928/23258160-20191031-18.
  8. Singh SR, Fung AT, Fraser-Bell S, Lupidi M, Mohan S, Gabrielle PH, Zur D, Iglicki M, M López-Corell P, Gallego-Pinazo R, Farinha C, Lima LH, Mansour AM, Casella AM, Wu L, Silva R, Uwaydat SH, Govindahari V, Arevalo JF, Chhablani J. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation. Br J Ophthalmol. 2019 Aug 10. pii: bjophthalmol-2019-314542. doi: 10.1136/bjophthalmol-2019-314542. [Epub ahead of print]
  9. Al-Khaled T, Mikhail M, Jonas KE, Wu WC, Anzures R, Amphonphruet A, Chuluunbat T, Wu L, Chiang MF, Campbell JP, Chan RVP. Training of Residents and Fellows in Retinopathy of Prematurity Around the World: An International Web Based Survey. J Ped Ophthalmol Strabismus 2019;
  10. ArevaloJF, Lasave AF, Kozak I, Al Rashaed S, Al Kahtani E, Maia M, Farah ME, Cutolo C, Brito M, Osorio C, Navarro P, Wu L, Berrocal MH, Morales-Canton V, Serrano MA, Graue-Wiechers F, Sabrosa NA, Alezzandrini AA, Gallego-Pinazo R. Preoperative Intravitreal Bevacizumab for Tractional Retinal DetachmentSecondary to Proliferative Diabetic Retinopathy: Prospective Randomized Clinical Trial of the Pan-American Collaborative Retina Study (PACORES) Group. Am J Ophthalmol. 2019 May 13. pii: S0002-9394(19)30227-2. doi: 10.1016/j.ajo.2019.05.007. [Epub ahead of print]
  11. Hanumunthadu D, van Dijk EHC, Dumpala S, Rajesh B, Jabeen A, Jabeen A, Ansari M, Mehta P, Shah S, Sarvaiya C, Meyerle C, Wu L, Banker A, Boon CJ, Chhablani J. Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy. J Ophthalmic Vis Res 2019;14:164-170.
  12. Sastre-Ibañez M, Martinez-Rubio C, Molina-Pallete R, Martinez-Lopez-Corell P, Wu L, Arevalo JF, Gallego-Pinazo R. Retinal Pigment Epithelial Tears. J Fr Ophtalmol 2019;42:63-72
  13. Goncalves MB, Alves BQ, Moura R, Magalhaes O Jr, Maia A, Belfort R Jr, de Avila MP, Zas M, Saravia M, Lousas M, Wu L, Arevalo JF, Pacheco KD, Johnson T, Farah ME, Rodriguez FJ, Maia M. Intravitreal Dexamethasone Implant Migration in the Anterior Chamber: A Multicenter Study from the Pan-American Collaborative Retina Study Group. Retina 2019 Feb 14. doi: 10.1097/IAE.0000000000002475. [Epub ahead of print]
  14. Salcedo H, Arciniegas D, Mayorga M, Wu L. The Role of the Water-Drinking Test in Medically Treated Open Angle Glaucoma Patients. J Fr Opthalmol 2018;41:421-424.
  15. Hanumunthadu D, van Dijk E, Gangakhedkar S, Goud A, Cheung GCM, Cherfan D, Sarvaiya C, Meyerle C, Boon C, Singh S, Wu L, Chhablani J. Gender Variation in Central Serous Chorioretinopathy. Eye 2018;32:1703-1709.
  16. Mansour AM, Foster RE, Gallego-Pinazo R, Moschos MM, Sisk RA, Chhablani J, Rojanaporn D, Sujirakul T, Arevalo JF, Lima LH, Wu L, Charbaji A, Saatci AO, Mansour HA, Martinez-Rubio C, Patel Y, Gangakhedkar S. Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Exudative Retinal Arterial Macroaneurysms. Retina 2018; Mar 2. doi: 10.1097/IAE.0000000000002131. [Epub ahead of print]
  17. Carrillo-Galvan L, Rios N, Lansingh VC, Lee A, Wu L, Lopez E. Analysis of Ophthalmological and Vision Related Publications in Latin America. Arq Bras Oftalmol 2018;81;24-29.
  18. Mansour AM, Chhablani J, Arevalo JF, Wu L, Sharma R, Sinawat S, Sujirakul T, Assi A, Vélez-Vázquez WM, Mansour MA, Kayikcioglu O, Kucukerdonmez C, Kal A. Retinal Detachment in Albinism. Clinical Ophthalmol 2018;12:1-6
  19. Roca JA, Wu L, Fromow-Guerra J, Rodriguez FJ, Berrocal MH, Rojas S, Lima LH, Gallego-Pinazo R, Chhablani J, Arevalo JF, Lozano-Rechy D, Serrano M. Yellow (577 nm) Micropulse Laser vs Half Dose Verteporfin Photodynamic Therapy in Eyes with Chronic Central Serous Chorioretinopathy: Results of the Pan American Collaborative Retina Study (PACORES) Group. Br J Ophthalmol 2018;102:1696-1700
  20. Huang S, Wu L. Retinal Vascular Diseases in the Asia Pacific: Shifting Paradigms for Management. Asia Pac J Ophthalmol 2018;7:1-2
  21. Acon D, Wu L. Multimodal Imaging in Diabetic Macular Edema. Asia Pac J Ophthalmol 2018;7:22-27
  22. Diaz-Valverde A, Wu L. To Peel or Not to Peel the Internal Limiting Membrane in Idiopathic Epiretinal Membranes. Retina 2018;38:S5-S11
  23. Schlottmann PG, Alezzandrini AA, Zas M, Rodriguez FJ, Luna JD, Wu L. New Treatment Modalities for Neovascular Age-Related Macular Degeneration. Asia Pac J Ophthalmol 2017;6:514-519.
  24. Chhablani J, Paulose RM, Lasave AF, Wu L, Carpentier C, Maia M, Lujan S, Rojas S, Serrano M, Berrocal MH, Arevalo JF. Intravitreal bevacizumab monotherapy in myopic choroidal neovascularization: 5 year outcomes for the Pan American Collaborative Retina Study Group. Br J Ophthalmol 2018;102:455-459
  25. Roca JA, Wu L, Berrocal M, Rodriguez F, Alezzandrini A, Alvira G, Velez-Montoya R, Quiroz-Mercado H, Fernando Arevalo J, Serrano M, Lima LH, Figueroa M, Farah M, Chico G. Un-Explained visual loss following silicone oil removal. Results of the Pan American Collaborative Retina Study (PACORES) Group. Int J Retina Vitreous 2017 2017 Jul 24;3:26. doi: 10.1186/s40942-017-0079-6. eCollection 2017.
  26. Pagano C, Wu M, Wu L. Acute Visual Loss and Intraretinal Hemorrhages Associated to Energy Drink Consumption. Int Ophthalmol 2017;37:1349-1351
  27. Novais E, Maia M, Mello PA, Dias J, Garcia JM, Andrade G, Louzada R, Ávila MP, Maia A, Arevalo JF, Wu L, Berrocal MH, Badaró E and Farah ME. Twelve-month follow-up of dexamethasone implants for macular edema from various diseases in vitrectomized and non-vitrectomized eyes. J Ophthalmol 2016 2016:7984576. Epub 2016 Sep 18.
  28. Chhablani J, Ambiya V, Yogi R, Li A, Shah S, Sarvaiya C, Mehta P, Meyerele C, Wu L, Singh R, Banker A. Subfoveal Choroidal Thickness as a Predictor of Central Serous Chorioretinopathy. Eye 2016;30:1623-1629.
  29. Arevalo JF, Lasave A, Wu L, Maia M, Diaz-Llopis M, Alezandrini AA, Brito M. Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy: Results from the Pan American Collaborative Retina Study Group. Retina 2017;37:334-343.
  30. Wu L, Zas M, Berrocal MH, Arevalo JF, Figueroa M, Rodriguez F, Serrano M, Graue F, Alezzandrini A, Gallego-Pinazo R, Roca JA, Iglicki M, Dalma-Weishauz J, Kozak I, Collado A, Badal J, Maia M, Salcedo-Villanueva G, Quiroz-Mercado H, Fromow-Guerra J, Lozano-Rechy D, Avila M, Chhablani J. Anatomical and Functional Outcomes of Symptomatic Idiopathic Vitreomacular Traction: A Natural History Study from the Pan American Collaborative Retina Study Group. Retina 2016;36:1913-1918.
  31. Arevalo JF, Lasave AF, Wu L, Acon D, Farah ME, Gallego-Pinazo R, Alezzandrini AA, Fortuna V, Quiroz-Mercado H, Salcedo-Villanueva G, Maia M, Serrano M, Rojas S. Intravitreal Bevacizumab for Diabetic Macular Oedema: 5 Year Results of the Pan American Collaborative Retina Study Group. Br J Ophthalmol 2016;100:1605-1610
  32. Arevalo JF, Lasave AF, Wu L, Acon D, Berrocal MH, Diaz-Llopis M, Gallego-Pinazo R, Serrano MA, Alezzandrini AA, Rojas S, Maia M, Lujan S. Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration: 5 Year Results of the Pan American Collaborative Retina Study Group. Retina 2016;36:859-867.
  33. Navarro R, Machado L, Maia Jr O, Wu L, Farah ME, Magalhaes Jr O, Arevalo JF, Maia M. Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment After Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study From the Pan Amaerican Collaborative Retina Study Group (PACORES). J Ophthalmol 2015;156910
  34. Chhablani J, Kozak I, Pichi F, Chenworth M, Berrocal MH, Rumneek B, Singh RP, Wu L, Meyerle C, Casella AM, Mansour A, Bashshur Z, Scorza A, Carral P, Nucci P, Arevalo JF. Outcomes of Treatment of Choroidal Neovascularization Associated with
    Central Serous Chorioretinopathy with Intravitreal Anti-Angiogenic
    Retina 2015;35:2489-2497.
  35. Wu L. When is Macular Edema Not Macular Edema? An Update on Macular Telangiectasia Type 2. Taiwan J Ophthalmol 2015;5:149-155.
  36. Wu L. Multimodality Imaging in Macular Telangiectasia 2: A Clue to Its Pathogenesis. Ind J Ophthalmol 2015;63:394-398.
  37. Gallego-Pinazo R, Dolz-Marco R, Berrocal M, Wu L, Maia M, Serrano M, Alezzandrini A, Arévalo JF, Díaz-Llopis M. Outcome of diabetic patients: Results of the Pan American Collaborative Retina Study Group. Arq Bras Oftalmol 2014;77:355-359
  38. Pascual-Camps I, Hernández-Martínez P, Monje-Fernández L, Dolz-Marco R, Gallego-Pinazo R, Wu L, Arévalo JF, Díaz-Llopis M. Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders. J Ophthalmic Inflamm Infect. 2014 Oct 15;4:26. doi: 10.1186/s12348-014-0026-8
  39. Caiado RR, Magalhães O Jr, Badaró E, Maia A, Novais EA, Stefanini FR, Navarro RM, Arevalo JF, Wu L, Moraes N, Farah ME, Maia M. Effect of Lens Status in the Surgical Success of 23 Gauge Primary Vitrectomy for the Management of Rhegmatogenous Retinal Detachment: the Pan American Collaborative Retina Study (PACORES) Group Results. Retina 2015;35:326-333
  40. Hernandez F, Alpizar-Alvarez N, Wu L. Chromovitrectomy: An Update. J Ophthalmic Vis Res 2014;9:1-9.
  41. Chhablani J, Wu L. Update on Choroidal Vascular Imaging Using Optical Coherence Tomography. Exp Rev Ophthalmol 2014;9:297-304.
  42. Wu L, Berrocal MH, Rodriguez FJ, Maia M, Morales-Canton V, Figueroa M, Serrano M, Roca JA, Arevalo JF, Navarro R, Hernandez H, Salinas S, Romero R, Alpizar-Alvarez N, Chico G. Intraocular Pressure Elevation Following Uncomplicated Pars Plana Vitrectomy. Results of the Pan American Collaborative Retina Study Group. Retina 2014;34:1985-1989.
  43. Gallego-Pinazo R, Hernandez-Martinez P, Hervás-Ontiveros A, Martinez-Castillo S, Dolz-Marco R, Arevalo JF, Wu L, Diaz-Llopis M. Local Safety Concerns of Repeated Dexamethasone Intravitreal Implant (Ozurdex) for Macular Diseases. J Ocul Diseases Therapeutics 2013;1:10-14.
  44. Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of Diabetic Retinopathy and Diabetic Macular Edema. World Journal of Diabetes 2013;4:290-294.
  45. Figueroa MS, Contreras I, Noval S, PACORES Study Group. Anatomic and Visual Outcomes of 23-G Vitrectomy Without Scleral Buckling for Primary Rhegmatogenous Retinal Detachment. Eur J Ophthalmol 2013;23:417-422
  46. Wu L, Alpizar-Alvarez N. Choroidal Imaging by Spectral Domain Optical Coherence Tomography. Taiwan J Ophthalmol 2013;3:3-13.
  47. Carpentier C, Zanolli M, Wu L, Sepulveda G, Berrocal MH, Saravia M, Diaz-Llopis M, Gallego-Pinazo R, Filsecker L, Verdaguer-Diaz JI, Milan Navarro R, Arevalo JF, Maia M. Residual ILM Following ERM Peeling: Results of the Pan American Collaborative Retina Study Group. Retina 2013;33:2026-2031.
  48. Wu L. Is Tissue Necrosis Factor Alpha an Important Target in Age-Related Macular Degeneration and Diabetic Macular Edema? Retina 2013;33:1287-1290.
  49. Arevalo JF, Serrano M, Wu L. Combined Inhibition of Tumor Necrosis Factor (TNF) and Vascular Endothelial Growth Factor (VEGF) for the treatment of Macular Edema of Various Etiologies: A Short Term Pilot Study. Eye (Lond). 2013;27:569-571.
  50. Wu L, Evans T, Arevalo JF. Idiopathic Macular Telangiectasia Type 2 (Idiopathic Juxtafoveolar Retinal Telangiectasis Type 2A).  Survey Ophthalmol DOI:10.1016/j.survophthal.2012.11.007
  51. Arevalo JF, Lasave AF, Wu L, Diaz-Llopis M, Gallego-Pinazo R, Alezzandrini AA, Berrocal MH. Intravitreal Bevacizumab Plus Grid Laser Photocoagulation or Intravitreal Bevacizumab or Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema: Results of the Pan American Collaborative Retina Study Group at 24 Months. Retina 2012  Dec 5 epub ahead of print.
  52. Wu L, Arevalo JF, Hernandez-Bogantes E, Regatieri C, Farah ME, Roca JA. Intravitreal TNF-Alpha Inhibitors for Neovascular AMD Sub-Optimally Responsive to Anti-VEGF Agents: A Pilot Study from the Pan American Collaborative Retina Study Group. J Ocular Pharmacol Therapeutics.  In Press
  53. Wu L, Hernandez-Bogantes E, Roca JA, Arevalo JF. Reply Retina 2012;32:2179-2180.
  54. Wu L, Arevalo JF, Hernandez-Bogantes E, Roca JA. Intravitreal Infliximab for Refractory Pseudo-phakic Cystoid Macular Edema: Results of the Pan American Collaborative Retina Study Group. Int Ophthalmol 2012;32:235-243.
  55. Arevalo JF, Sanchez JG, Saldarriaga L, Berrocal MH, Fromow-Guerra J, Morales-Canton V, Wu L, Maia M, Saravia MJ, Bareño J. Retinal Detachment After Bevacizumab. Ophthalmology 2011;118:2304.e3-7
  56. Arevalo JF, Sanchez JG, Lasave AF, Wu L, Maia M, Bonafonte S, Brito M, Alezzandrini AA, Restrepo N, Berrocal MH, Saravia M, Farah ME, Fromow-Guerra J, Morales-Canton V. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture. J Ophthalmol 2011;2011:584238.
  57. Martinez J, Hernandez-Bogantes E, Wu L. Diabetic Retinopathy Screening with Single Field Digital Fundus Photography at a District Level in Costa Rica: A Pilot Study.  Int Ophthalmol 2011;31:83-88. 
  58. Wu L, Berrocal MH, Arevalo JF, Carpentier C, et al. Endophthalmitis Post Pars Plana Vitrectomy: Results of the Pan American Collaborative Retina Study Group.  Retina 2011;31:673-678.
  59. Arevalo JF, Adan A, Berrocal MH, Espinoza JV, Maia M, Wu L, Roca JA, Quiroz-Mercado H, Ruiz-Moreno JM, Serrano MA.  Intravitreal Bevacizumab for Inflammatory Choroidal Neovascularization: Results from the Pan American Collaborative Retina Study Group at 24 Months.  Retina 2011;31:353-363
  60. Wu L, Evans T. Immediate Changes in Intraocular Pressure After an Intravitreal Injection of 2.5 mg of Bevacizumab. Arch Soc Esp Oftalmol 2010;85:364-369.
  61. Penha FM, Maia M, Cardillo JA, Arevalo JF, Wu L, Rodriguez FJ, Berrocal MH, Farah ME. Comparison of a Single Intravitreal Injection of Bevacizumab vs Triamcinolone Acetonide as Primary Treatment for Diffuse Diabetic Macular Oedema. Acta Ophthalmol 2012;90:e160-161.
  62. Wu L, Evans T. An Intravenous Microdose of Bevacizumab  for the Treatment of Pigment Epithelial Detachment Associated to Age-Related Macular Degeneration Refractory to Intravitreal Bevacizumab: A Case Report. Retinal Cases and Brief Reports. doi: 10.1097/ICB.0b013e3181f66d28
  63. Arevalo JF, Sanchez JG, Lasave AF, Wu L, Maia M, Bonafonte S, Brito M, Alezzandrini AA, Restrepo N, Berrocal MH, Saravia M, Farah ME, Fromow-Guerra J, Morales-Canton V. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy at 24 Months: The 2008 Juan Verdaguer-Planas Lecture. Curr Diabetes Rev 2010;6:313-322
  64. Arevalo JF, Sanchez JG, Wu L, Berrocal MH, Alezzandrini AA, Restrepo N, Maia M, Farah ME, Brito M, Diaz-Llopis M, Rodriguez FJ, Reategui G, Iturralde-Iraola J, Udaondo-Mirete P. Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at 24 Months: The Pan American Collaborative Retina Study Group. Ophthalmology 2010;117:1974-1981.
  65. Wu L, Hernandez-Bogantes E, Roca JA, Arevalo JF, Barraza K, Lasave A. Intravitreal TNF Inhibitors in the Treatment of Refractory Diabetic Macular Edema: A pilot Study from the Pan American Collaborative Retina Study Group. Retina 2011;31:298-303
  66. Wu L, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Canton V, Alezzandrini AA, Diaz-Llopis MJ. Comparison of Two Doses of Intravitreal Bevacizumab as Primary Treatment for Macular Edema Secondary to Central Retinal Vein Occlusions: Results of the Pan American Collaborative Retina Study Group at 24 Months.  Retina 2010;30:1002-1011.
  67. Wu L, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Canton V, Alezzandrini AA, Diaz-Llopis MJ. Comparison of Two Doses of Intravitreal Bevacizumab as Primary Treatment for Macular Edema Secondary to Branch Retinal Vein Occlusions: Results of the Pan American Collaborative Retina Study Group at 24 Months. Retina 2009;29(10):1396-1403.
  68. Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L. Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema: The Pan American Collaborative Retina Study Group Results. Ophthalmology 2009;116(8):1481-1487.e1
  69. Arevalo JF, Sanchez JG, Wu L, Maia M, Alezzandrini AA, Brito M, Bonafonte S, Lujan S, Diaz-Llopis M, Restrepo N, Rodriguez FJ, Udaondo-Mirete P. Primary Intravitreal Bevacizumab for Diffuse Macular Edema: The Pan American Collaborative Retina Study Group at 24 Months. Ophthalmology 2009;116(8):1488-1497.e1.
  70. Arevalo JF, Sanchez JG, Fromow-Guerra J, Wu L, Berrocal MH, Farah ME, Cardillo J, Rodriguez FJ. Comparison of 2 Doses of  Primary Intravitreal Bevacizumab (Avastin) for Diffuse Diabetic Macular Edema: Results from the Pan American Collaborative Retina Study Group (PACORES) at 12 Months Follow-Up. Graefes Arch Clin Exp Ophthalmol 2009;247(6):735-743.
  71. Cohen D, Rambeloarisoa, Florea L, Leye YM, Deplus S, Gaudric A, Farge-Bancel D, Wu L, Davis J. Diagnostic and Therapeutic Challenges. Retina 2009;29:117-120
  72. Arevalo JF, Wu L, Sanchez JG, Maia M, Saravia M, Fernandez CF, Evans T. Intravitreal bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: 6 months follow-up. Eye 2009;23:117-123
  73. Wu L, Arevalo JF, Maia M, Berrocal MH, Sanchez J, Evans T. Comparing Outcomes in Patients with Subfovel Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Treated with Two Different Doses of Primary Intravitreal Bevacizumab: Results of the Pan-American Collaborative Retina Study Group (PACORES) at the 12-Month Follow-up. Jap J Ophthalmol 2009;53(2):125-130.
  74. Wu L, Evan T, Saravia M, Schlaen A, Couto C. Intravitreal bevacizumab for choroidal neovascularization secondary to the Vogt Koyanagi Harada Syndrome. Jap J Ophthalmol 2009;53(1):57-60.
  75. Wu L, Tapia-Herrera G. Fungal Endophthalmitis. Current Fungal Infections Reports 2009;3:55-61.
  76. Arevalo JF, Garcia RA, Wu L, Rodriguez FJ, Dalma-Weishauz J, Quiroz-Mercado H, Morales-Canton V, Roca JA, Berrocal MH, Graue-Wiechers F, Robledo V. Radial Optic Neurotomy. Results of the Pan American Collaborative Retina Study Group (PACORES). Retina 2008;28(8):1044-1052
  77. Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia M, Costa RA. Primary Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of the Pan-American Collaborative Retina Study Group at 12-months Follow-up. Retina 2008;28(10):1387-1394.
  78. Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodrihuez FJ, Evans T, Costa RA, Cardillo J. Comparison of 2 Doses of Intravitreal Bevacizumab (Avastin®) for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Results from the Pan-American Collaborative Retina Study Group at 6-Month Follow-Up. Retina 2008;28:212-219. 
  79. Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, Farah ME, Pieramici DJ, Berrocal MH, Sanchez JG. Tractional Retinal Detachment following Intravitreal Bevacizumab (Avastin®) in patients with Severe Proliferative Diabetic Retinopathy. Br J Ophthalmol 2008;92:213-216.
  80. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ. Twelve month Safety of Intravitreal Injections of Bevacizumab (Avastin): Results of the Pan American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008;246:81-87
  81. Wu L, Evans T. Arevalo JF, Rodriguez FJ, Berrocal MH, Hsu M. Long Term Effect of Intravitreal Triamcinolone in the Nonproliferative Stage of Type II Idiopathic Parafoveal Telangiectasia. Retina 2008;28:314-319.
  82. Wu L, Velasquez R, Montoya O. Non-Infectious Endophthalmitis Associated with Trypan Blue Use in Cataract Surgery. International Ophthalmology 2008;28:89-93.
  83. Arevalo JF, Garcia-Amaris RA, Roca JA, Sanchez JG, Wu L, Berrocal MH, Maia M. Primary Intravitreal Bevacizumab (Avastin) for the Management of Pseudophakic Cystoid Macular Edema: A Pilot Study from the Pan-American Collaborative Retina Study Group. J Cataract Refractive Surgery 2007;33:2098-2105.
  84. Sanchez JG, Garcia RA, Wu L, Berrocal MH, Graue-Wiechers F, Rodriguez FJ, Robledo V, Lizana C, Pikulich Z, Mendoza AJ, Velez-Vasquez W, Arevalo JF. Optical Coherence Tomography Characterisitics of Group 2A Idiopathic Parafoveal Telangiectasis. Retina 2007;27:1214-1220.
  85. Arevalo JF, Sanchez JG, Garcia RA, Wu L, Berrocal MH, Rodriguez FJ, Rodriguez A, Novoa LA, Garcia-Amaris R. Indocyanine green mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.  Graefes Arch Clin Exp Ophthalmol 2007;245:1673-1680.
  86. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M,Berrocal MH, Solis-Vivanco A, Farah ME, Rodriguez FJ. Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema: Results of the Pan-American Collaborative Retina Study Group at 6-months Follow-up. Ophthalmology 2007;114:743-750.
  87. Wu L, Evans T, Tapia-Herrera G. The XXVII Pan American Congress of Ophthalmology. Expert Rev Ophthalmol 2007;2:533-534.
  88. Wu L, Calderón M, Marbis J, Hernandez, G, Ramirez V. Bilateral Exudative Retinal Detachment as the First Sign of Relapsing Acute Myelogenous Leukemia. Clin Exp Ophthalmol 2006;34(6):623-625
  89. Wu L, Flikier D. Corneal Graft Dehiscense During Pneumatic Retinopexy. Retina 2006;26(6):707.
  90. Wu L, Murphy RP. Photodynamic therapy in choroidal neovascularization.  Curr Opin Ophthalmol. 1999;10:217-220.
  91. Maxwell DP, Brent BD, Diamond JG and Wu L. Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis.  Ophthalmology 1991; 98: 1370-1375.
  92. Baricos WH, Cortez SL, Le QC, Wu L, Shaw E, Hanada K, Shah SV. Evidence suggesting a role for Cathepsin L in an experimental model of glomerulonephritis. Arch Biochem Biophys 1991;288(2):468-472.
  93. Baricos WH, O’Connor SE, Cortez S, Wu L and Shah SV. The cysteine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis.  Biochem Biophys Res Comm 1988; 155: 1318-1323.